The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
– Written by
David Woodsmith
STORY LINK British Pound to Dollar Forecast: GBP Coils Below 1.32
The Pound-to-Dollar exchange rate (GBP/USD) hovered around 1.3160 on Tuesday, holding a narrow range despite a sharp rise in global market volatility.
With equity markets sliding and safe-haven demand resurfacing, traders are braced for a breakout from the tight band that has contained the pair so far this week.
Although there has been a wider increase in volatility, the Pound to Dollar rate has been held in relatively narrow ranges and settled little changed around 1.3160.
On a near-term view, UOB commented; “Today, we continue to expect GBP to trade in a range, most likely between 1.3125 and 1.3185.”
Narrow ranges, however, are unlikely to persist given wider market conditions.
ING has a year-end GBP/USD forecast of 1.34.
Get better rates and lower fees on your next international money transfer.
Compare TorFX with top UK banks in seconds and see how much you could save.
The Pound has been hurt by a slide in risk appetite with another round of significant FTSE 100 index losses on Tuesday. Weaker risk conditions tend to hurt the Pound and benefit the dollar, but there is uncertainty whether the dollar can benefit this time, especially if the focus is on US tech stocks.
ING commented; “The risk-off environment at the start of the week is prompting a return of safe-haven demand for the dollar. While valuation concerns ahead of tomorrow’s Nvidia earnings release appear to be a key driver of the equity sell-off, the move has been global – not confined to US markets.”
It added; “That’s what matters most for FX: as long as the sell-off is broad-based, the dollar can benefit from safe-haven flows.”
Federal Reserve policy will also be a key element with markets pricing in just under a 50% chance of a Fed rate cut at the December 10th meeting.
Overnight, Fed Governor Waller called for a further cut in December with fellow Governor Jefferson also suggesting he would back a cut, but other committee members will oppose a move.
Traders will be wary over the potential for guidance and labour-market data this week could be pivotal.
Danske Bank commented; “It is relatively rare for a Fed decision to remain a coin flip this close to the meeting; if the data fail to provide sufficient guidance, Powell and other Fed officials may step in with clearer communication to avoid entering the blackout period without a defined market stance.”
It also noted multiple forces on the dollar but added; “Nevertheless, we expect the USD to end the year stronger if the Fed does not cut in December, despite the recent disconnect between front-end yields and the greenback.”
MUFG noted dovish Fed talk and added; “As a result, we are sticking to our call for another Fed cut in December unless evidence emerges of a strong pick-up in labour demand in the month ahead. It remains a key assumption behind our forecasts for a weaker US dollar.”
International Money Transfer? Ask our resident FX expert a money transfer question or try John’s new, free, no-obligation personal service! ,where he helps every step of the way,
ensuring you get the best exchange rates on your currency requirements.
TAGS: Pound Dollar Forecasts
The global Nutraceuticals Market is entering a defining growth phase as consumers worldwide continue shifting toward preventive healthcare, clean-label nutrition, and functional wellness solutions. With increased emphasis on immunity, digestive health, metabolic support, and lifestyle-driven nutrition, nutraceuticals have evolved into a mainstream component of daily dietary habits. According to the latest industry assessment, the market is projected to rise from USD 702 billion in 2025 to USD 1,128 billion by 2032, expanding at a CAGR of 7.0%. The expansion is shaped by advances in functional food formulation, rapid innovation in dietary supplements, growing retail penetration, and rising consumer willingness to invest in premium wellness products.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):
https://www.fairfieldmarketresearch.com/report/nutraceuticals-market/request-sample
Market Insights
Global demand for nutraceuticals continues to accelerate as health awareness intensifies across all demographics. Functional foods remain widely preferred for their convenience and nutritional value, while dietary supplements continue gaining traction thanks to expanding clinical validation and broader product availability. The rise of personalized nutrition and microbiome-focused wellness is reshaping product development trends, encouraging manufacturers to integrate science-backed ingredients such as botanicals, omega fatty acids, amino acids, fibers, and specialty carbohydrates. Additionally, the expanding presence of online distribution channels is enabling faster reach, competitive pricing, and easy accessibility to a diverse product portfolio. As consumers prioritize long-term wellbeing, nutraceutical brands are adopting transparent labeling, sustainable sourcing, and enhanced traceability to build trust and differentiate in an increasingly competitive landscape.
Explore the Full Report:
https://www.fairfieldmarketresearch.com/report/nutraceuticals-market
Drivers
Growing interest in preventive healthcare is the primary driver fueling nutraceutical adoption, with consumers proactively seeking products that address chronic lifestyle conditions, boost immunity, and support overall vitality. The global rise in lifestyle-related disorders, including obesity, cardiovascular conditions, and diabetes, is further accelerating product demand. Evolving dietary habits, urbanization, increasing disposable incomes, and heightened fitness awareness collectively contribute to consistent market expansion. Regulatory encouragement through structured guidelines for safety, quality, and fortification also supports industry growth. The addition of clean-label, plant-based, and organic formulations is attracting health-conscious consumers, while technological advancements in extraction, encapsulation, and fermentation techniques enhance ingredient stability and efficacy.
Business Opportunity
Significant business opportunities exist across product innovation, digital retail expansion, and specialty nutrition categories. Companies focusing on targeted nutritional solutions-such as probiotic-infused foods, protein-rich supplements, botanical blends, and metabolic health enhancers-are poised for strong growth. Partnerships between research organizations and nutraceutical manufacturers are enabling faster commercialization of science-backed ingredients with clinically validated benefits. Brands leveraging e-commerce, subscription-based nutrition boxes, AI-driven diet personalization, and direct-to-consumer wellness platforms are expanding market penetration. Furthermore, emerging markets across Asia, Latin America, and the Middle East offer high-growth potential due to rising health consciousness and expanding middle-class populations. Sustainable packaging, transparency initiatives, and ethical sourcing present added opportunities for differentiation.
Region Analysis
North America continues to hold a strong position driven by established healthcare awareness, high purchasing power, and widespread adoption of functional foods and supplements. The region benefits from advanced product innovation and strong regulatory frameworks supporting product quality. Europe exhibits sustained demand for natural ingredients, botanical extracts, and clean-label offerings, supported by strict nutritional guidelines and well-informed consumers. Asia Pacific is the fastest-expanding regional landscape, driven by rapid urbanization, rising disposable incomes, and growing acceptance of functional wellness products. Countries such as China, India, Japan, and South Korea are witnessing significant growth in supplement consumption, fortified foods, and herbal nutrition. Latin America is gaining momentum as consumers increasingly prioritize immune health and metabolic wellness. Meanwhile, the Middle East & Africa presents growing opportunities with rising retail penetration, expanding healthcare infrastructure, and increasing awareness of lifestyle nutrition.
Key Players
Major companies shaping the global nutraceuticals landscape include:
• BASF Corporation
• Cargill Inc
• DSM
• Lonza
• Corbion
• Ingredion Incorporated
• Archer-Daniels-Midland Company
• Friesland Campina
• Kerry PLC
• Olam International Ltd.
Contact US:
Fairfield Market Research
G04 Golden Mile House, Clayponds Lane, Brentford, London TW8 0GU
Office:+44 (0) 203 892 0037
Mobile:+44 (0) 7538 426 479
Email: sales@fairfieldmarketresearch.com
Web:www.fairfieldmarketresearch.com
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
This release was published on openPR.
Jakarta, Pintu News – Ripple is currently at a tipping point, with the price trying to stabilize in an important technical zone after several weeks of controlled declines. The token is trading at around $2.16, where it continues to test the 0.382 Fibonacci region. This level has become an important reference point for traders watching the next move of the decision, as the market structure weakens and momentum slows down.
XRP continues to follow a clear pattern of lower highs and lower lows on the 4-hour chart. The price is below the 9 EMA and below the Supertrend, which signals continued selling pressure. This suggests that there is still a dominant selling force in the market, which could affect the next price movement.
Open interest for XRP futures has risen sharply throughout 2025. Open interest grew from under $1 billion in early October to a peak of over $6 billion as volatility increased. The leveraged positions returning to the market indicate significant strength, which could influence future price dynamics.
Read also: 10 Layer-1 Crypto that Potentially Reach ATH in 2026
The capital flow data shows consistent outputs throughout 2025. Outflows between $30 million and $150 million appear frequently, indicating continued distribution by large holders. This could be an indicator that there is a tendency to sell rather than buy among large holders, which could affect price stability.

XRP’s near-term outlook depends on whether buyers can hold the $2.16-$2.17 support zone long enough to build momentum towards the $2.25-$2.33 region. Technical compression and increasing leverage both suggest that high volatility is likely in the upcoming sessions.
The XRP price is hovering around $2.16 and continues to test the Fibonacci level of 0.382, which became an important technical area after several weeks of decline. This level determines whether the trend structure can hold or weaken further.
Selling pressure is still dominant, reflected in the price position below EMA 9 and Supertrend. Distribution by large holders throughout 2025 also reinforces the pressure.
Open interest increased from early October 2025, growing from under $1 billion to over $6 billion by November. This rise coincided with increased volatility in the market.
The critical support zone is in the $2.16-$2.17 range, which is the focus in determining whether prices can maintain short-term stability.
Outflows between $30 million and $150 million indicate a sell-off by large holders during 2025. This indicates weak accumulation and consequent price pressure.
That’s the latest information about crypto. Follow us on Google News to get the latest crypto news about crypto projects and blockchain technology. Also, learn crypto from scratch with complete discussion through Pintu Academy and stay up-to-date with the latest crypto market such as bitcoin price today, xrp coin price today, dogecoin and other crypto asset prices through Pintu Market.
Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app through Google Play Store or App Store now. Also, get a web trading experience with various advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro.
*Disclaimer
This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Trading crypto carries high risk and volatility, always do your own research and use cold hard cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.
Reference
Many studies have been performed on various naturally occurring herbs and other compounds, demonstrating their ability to lower blood sugars.
While many of these compounds decrease the blood glucose level by stimulating the pancreas to produce more insulin, one particular herb, Goat’s Rue or French Lilac, chemically known as guianidine, is particularly effective in reducing the blood glucose level utilizing a different mechanism.
(also known as Goat’s Rue, French Lilac, Italian Fitch or Professor-weed) is a plant from the Galega genus of the Faboideae.
Medical Use
Galega officinalis has been known since the Middle Ages for relieving the symptoms of diabetes mellitus. Upon analysis, it turned out to contain guanidine, a substance that decreases blood sugar by decreasing insulin resistance.
Chemical derivatives from the biguanide class of medication include metformin (Glucophage, commonly prescribed for diabetics) and the older, withdrawn agent phenformin.
This herb actually decreases the cellular resistance to insulin, allowing the cells to utilize the insulin more efficiently in metabolizing glucose. It also decreases the absorption of glucose from the small intestine. It reduces the formation of glucose in the liver, and it increases the uptake and utilization of glucose in the fat and muscle cells throughout the body. Non-insulin dependent diabetics are able to better maintain blood glucose levels closer to the normal range, while insulin dependent diabetics are often able to reduce their insulin dosage and more easily maintain stable levels of the blood glucose.
Ginseng refers to species within Panax, a genus of 11 species of slow-growing perennial plants with fleshy roots, in the family Araliaceae. They grow in the Northern Hemisphere in eastern Asia (mostly northern China, Korea, and eastern Siberia), typically in cooler climates.
Medical Use
Both American and Panax (Asian) ginseng rhizomes are taken orally as adaptogens, aphrodisiacs, nourishing stimulants, and in the treatment of type II diabetes, including sexual dysfunction in men. It appears that ginseng increases the sensitivity of cells to insulin, a hormone that sends the signal to cells to reduce blood sugar by taking up glucose. Ginseng may also increase the secretion of insulin.
In a randomized, placebo-controlled study published in the September issue of Diabetes Care, researchers gave capsules of North American ginseng (Panax quinquefolius) to diabetic subjects who were already receiving treatment for diabetes in the form of diet or prescription drugs. In their analysis, the researchers found that subjects receiving a 3g dose of ginseng had a blood sugar level that was 59.1% less than subjects who had received the placebo treatment.
Ginseng should be used therapeutically only with the advice of a trained health practitioner. Although subjects in the study did not report major side effects, ginseng can potentially augment the effect of prescription drugs used to lower blood sugar, causing a dangerous decrease in blood sugar. Adverse effects with concurrent use of oral anti-diabetic drugs, such as Warfarin, heparin, aspirin, and NSAIDS are another possibility.

Cinnamon is the inner bark of a tropical evergreen tree. The two main varieties are Cinnamomum cassia and Cinnamomum zeylanicum.
Medical Use
American scientists have claimed that a teaspoon of cinnamon a day may help prevent the onset of diabetes. Scientists at the US Agricultural Research Services’ nutrition laboratories in Beltsville, Md., found that an extract of cinnamon can actually revitalize the body’s ability to be far more responsive to insulin in peripheral tissues, e.g. adipose and muscle tissue. In fact, in laboratory experiments, glucose processing was increased by up to 20 times. The chemical responsible is called methylhydroxy chalcone polymer. Experiments on mice found that abnormally high glucose concentrations fell dramatically when given this cinnamon derivative.
The results of another study from 2003 in Pakistan showed lower levels of fasting glucose, triglycerides, LDL cholesterol and total cholesterol after 40 days with levels continuing to drop for 20 days after that.
The study was made up of 60 people with Type 2 diabetes who were divided into 6 groups of 10. Three groups received cinnamon in the form of capsules totaling 1, 3 or 6 grams of cinnamon a day. The other three groups received placebo capsules. The capsules were taken three times a day, after meals. All three levels of cinnamon showed results, leading researchers to believe that as little as 1 gram a day of cinnamon may benefit people who have Type 2.
Type II diabetics should take a quarter to one full teaspoon of cinnamon per day.
Cinnamon has long been known as an “energizing” spice, and it is likely that increasing the intake of this common and cheaply available food will benefit even non-diabetics, if used as a daily energizing tonic.
Cinnamon is also a rich source of magnesium, which is essential for maintaining bone density, electrolyte balance, certain enzyme functions and many other crucial biochemical processes. Magnesium is also linked to the more dramatic forms of diabetes that occur earlier in life.
Momordica charantia is a tropical and subtropical vine of the family Cucurbitaceae, widely grown for edible fruit, which is among the most bitter of all vegetables. English names for the plant and its fruit include bitter melon or bitter gourd. It is widely grown in India (Karela करेला in Hindi), Pakistan (Karela کریلا in Urdu, اردو),(komboze کمبوزه in Persian), South Asia, Southeast Asia, China, Africa and the Caribbean.
Medical Use
Bitter melon has been observed to have blood sugar-lowering effects, but there is only limited research specifically using bitter melon in humans. Clinical studies show that bitter melon increases the production of beta cells in the pancreas which leads to improvement in the insulin production of the body.
Many studies show that bitter melon is able to reduce the blood sugar levels in the body. Charantin, polypeptide P, and oleonolic acid glcosides are some of the ingredients of bitter melon that are essential in diabetes treatment. Charantin consists of mixtures of natural steroids which are shown to reduce blood sugar levels in the body. Polypeptide P, contains alkaloids that can also promote healthy blood sugar levels. Oleanolic acid glycosides, on the other hand, may prevent the retention of sugar from the intestines. Improvements in these area leads to improved insulin levels in the body.
Fresh juice of two karelas (approximately 20ml) should be taken on empty stomach in the early morning daily. The regular practice of this gives enormous benefits to the diabetics.

It is a natural, efficacious, an antioxidant with the richest natural source ofVitamin C.
Medical Use
Amalaki is a carminative and stomachic. It is used in Ayurveda as a cardiotonic, aphrodisiac, antipyretic, antidiabetic, cerebral and gastrointestinal tonic. It raises the total protein level and increases the body weight due to positive nitrogen balance. It has been found to have an anabolic effect.
Fresh amla juice of 10ml and 2 grams pure haldi (turmeric) powder well mixed and taken twice a day, effectively maintains the sugar level and imparts many side benefits like strength and vitality.
Besides, this herb, due to its high vitamin C content, is effective in controlling diabetes. A tablespoon of its juice mixed with a cup of bitter gourd juice, taken daily for two months. Will stimulates the pancreas and enable is to secrete insulin, thus reducing the blood sugar in the diabetes. Diet restrictions should be strictly observed while taking this medicine. It will also prevent eye complication in diabetes.
It is a plant product that has been used for a variety of medicinal and other purposes, and may be used in the treatment of diabetes. Fenugreek is a member of the Leguminosae, or Fabaceae, family and grows well in India, Egypt and other parts of the Middle East. The part used medicinally is the seeds.
Medical Use
Fenugreek seeds contain alkaloids, including trigonelline, gentianine and carpaine compounds. The seeds also contain fiber, 4-hydroxyisoleucine and fenugreekine, a component that may have hypoglycemic activity. The mechanism is thought to delay gastric emptying, slow carbohydrateabsorption and inhibit glucose transport.
Fenugreek may also increase the number of insulin receptors in red blood cells and improve glucose utilization in peripheral tissues, thus demonstrating potential anti-diabetes effects both in the pancreas and other sites. The amino acid 4- hydroxyisoleucine, contained in the seeds, may also directly stimulate insulin secretion.
There are only a few published studies on fenugreek. In one study, published in a 1990 issue of the European Journal of Clinical Nutrition, 10 patients on insulin therapy for type 1 diabetes were assigned to either placebo or 50 grams of defatted fenugreek-seed powder twice daily in addition to their insulin therapy.
Fasting glucose decreased from an average of 272 mg/dl at baseline to 196 mg/dl. There was also a decrease in total cholesterol, LDL (“bad”) cholesterol and triglycerides.
A larger study, published in a 1996 issue of Nutrition Research, involved a six-month trial of fenugreek in 60 patients with inadequately controlled type 2 diabetes. Twenty-five grams of powdered fenugreek seed was given twice daily at lunch and dinner in addition to the current diabetes therapy.
The average fasting glucose decreased from 151 mg/dl to 112 mg/dl after 6 months. Glucose values one and two hours after meals also declined. Average A1C decreased from 9.6% to 8.4% after eight weeks. To help your diabetes symptoms, try taking 2.5 g of fenugreek with your meals, a couple of times a day. This should help to control your blood sugar levels and increase your insulin production.
Botanically it is known as Polianthes tuberosa. It is a large tree 20 to 60 ft. high or sometimes more. The bark, fruits and seeds of the tree are medicinal. The bark is very astringent and is given in sore throat, bronchitis, asthma, ulcers and dysentery; it is also used for purifying blood. The fresh juice of the bark with goat’s milk is given in diarrhoea. The seeds are very useful diabetes. The fruit juice cures burning sensation of hands and feet. It subsides excessive heat in the body.
Medical Use
To control diabetes, 2-teaspoon powder of dry jambul fruits is taken twice a day or eating of fresh jumbul fruits is also recommended. Three to five grams of powdered seed with salt taken twice a day for a few days eliminates sugar.
A regular check should be kept on the blood sugar level, and if it settles in the normal range, no further treatment is needed.
Disclaimer
The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Copper price confirmed its surrender to the bearish corrective bias by forming new bearish wave to settle near $4.9000 level, the negative factors that are represented by holding below the barrier at$5.2000 and providing extra negative momentum by stochastic, which might increase the chances of attacking the extra support at $4.7500, then monitor its behavior to detect the expected targets in the near and medium trading.
While breaking $4.7500 level will increase the efficiency of the corrective track, forcing it to suffer extra losses by reaching $4.6300 and $4.4600, while its success in surpassing $5.2000 level will confirm its readiness to form strong bullish waves, to expect targeting $5.3200 and $5.5000 initially.
The expected trading range for today is between $4.7500 and $5.1200
Trend forecast: Bearish
The EURJPY pair faced stochastic negativity by providing new bullish close above 179.30 level, forming extra support for the bullish attempts, waiting for gathering extra momentum to ease the mission of surpassing 180.60 level, to confirm the continuation of the bullish scenario, to expect its rally towards 180.95 reaching the next main target at 181.55.
The risk of delaying the bullish attack is represented by the attempt of breaking 178.60 level, which forces it to activate the bearish corrective track, and forcing it to suffer some losses by reaching 177.65 and 177.05.
The expected trading range for today is between 179.30 and 180.60
Trend forecast: Bullish
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Thiamine Market Size By 2025?
The thiamine market has experienced robust expansion recently, projected to escalate from its 2024 valuation of $1.37 billion to $1.5 billion in 2025, reflecting a compound annual growth rate of 9.4%. This upward trajectory during the past period is attributable to several factors, including the proliferation of food fortification initiatives, the wider availability of functional food products, an escalating preference for naturally derived and organic options, heightened consumer appetite for functional foods, and more extensive fortification endeavors.
How Big Is the Thiamine Market Size Expected to Grow by 2029?
Anticipating robust expansion, the thiamine market is projected to reach a valuation of $2.13 billion by 2029, propelled by a consistent compound annual growth rate of 9.2%; this upward trajectory is underpinned by several key factors, such as heightened global consciousness regarding wellness, demographic shifts toward an older populace, an escalating prevalence of long-term health conditions, a growing consumer desire for ingredients sourced naturally and organically, and the expanding frequency of ailments associated with modern living. Furthermore, significant directional shifts influencing this market over the coming years encompass progressive technological innovations, intensified efforts in research endeavors, the incorporation of thiamine solutions within telemedicine frameworks and digital healthcare systems, deeper exploration into its uses for medical treatments, and the adoption of nutrition strategies tailored to individual needs.
View the full report here:
https://www.thebusinessresearchcompany.com/report/thiamine-global-market-report
Which Key Market Drivers Powering Thiamine Market Expansion and Growth?
Anticipated expansion in the need for dietary supplements is projected to fuel the upward trajectory of the thiamine market in the future.Manufactured items designed to augment an individual’s nutritional intake via oral consumption of forms such as pills, capsules, tablets, powders, or liquids are classified as dietary supplements.This surge in the consumption of dietary supplements is attributable to greater public consciousness regarding wellness, a growing inclination toward proactive health maintenance, and elevated focus on bolstering immune defenses.Thiamine is incorporated into these supplements to ensure consumers receive adequate quantities of this vital nutrient, which plays a critical role in essential physiological processes like generating energy, maintaining the nervous system’s integrity, supporting cardiac performance, aiding digestion, facilitating stress regulation, and sustaining overall metabolic balance.Illustratively, data from Nutrition Integrated, a UK-based business-to-business service, indicated that between January 2022 and January 2024, European availability of transparent protein powder products climbed by 159 percent, whilst in the UK specifically, consumer acquisitions of clear protein powders experienced a substantial 216 percent increase throughout 2023 when contrasted with the figures from 2022.Consequently, this escalating requirement for nutritional supplements acts as a key catalyst propelling the expansion of the thiamine market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16552&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Thiamine Market?
Key players within the thiamine market are concentrating efforts on forging ahead with novel offerings, exemplified by vitamin B1 deficiency infusions, as a strategy to solidify their standing. This therapeutic intravenous delivery involves introducing thiamine, or Vitamin B1, straight into the vascular system for medicinal purposes. Notably, in June of 2023, Lupin Limited, hailing from India, brought to market its thiamine hydrochloride injection (USP) available in multi-dose presentations holding 200 mg per 2 mL (equating to 100 mg per mL). Such an injectable preparation presents an effective, immediate route for patients grappling with difficulties in absorbing oral supplements, perhaps due to underlying digestive issues or critical deficiencies requiring prompt intervention, thereby furnishing medical professionals with a dependable method for rectifying and stabilizing vitamin B1 metrics, possibly lessening complications associated with extended deficits.
What Are the Emerging Segments in the Thiamine Market?
The thiaminemarket covered in this report is segmented –
1) By Product Type: Thiamine Mononitrate; Thiamine Hydrochloride; Thiamine Pyrophosphate
2) By Form: Tablets And Capsules; Liquid; Powder
3) By Application: Food And Beverages; Pharmaceuticals; Animal Feed; Dietary Supplements; Other Applications
Subsegments:
1) By Thiamine Mononitrate: Powder; Granules; Tablets
2) By Thiamine Hydrochloride: Powder; Injectable Form; Tablets
3) By Thiamine Pyrophosphate: Powder; Injectable Form
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16552&type=smp
Who Are the Global Leaders in the Thiamine Market?
Major companies operating in the thiamine market are BASF SE, Koninklijke DSM N.V., The Nature’s Bounty Co. Ltd., Zhejiang Medicine Co. Ltd., Swanson Health Products Inc., Brother Enterprises Holding Co. Ltd., NOW Health Group Inc., Molekula Group, Nutricost LLC, Solgar Inc., Tokyo Chemical Industry Co. Ltd., HPC Standards GmbH, Puritan’s Pride Inc., Loba Chemie Pvt. Ltd., Aland Nutraceuticals Group, Anhui Tiger Biotech Co. Ltd., Caisson Laboratories Inc., Chemizo Enterprise, General Nutrition Centers Inc., Huazhong Pharmaceutical Co. Ltd.
Which are the Top Profitable Regional Markets for the Thiamine Industry?
Asia-Pacific was the largest region in the thiamine market in 2024. The regions covered in the thiamine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16552
This Report Supports:
1.Business Leaders & Investors – To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers – To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators – To track industry developments and align regulatory frameworks.
4.Consultants & Analysts – To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Solana (SOL) price trades around $140 at the time of writing on Wednesday after rebounding from a key support level the previous day. Canary Capital and Fidelity announced the launch of their spot Solana Exchange Traded Funds (ETFs), SOLC and FSOL, on Tuesday, lifting market sentiment amid growing institutional interest. The technical outlook suggests further upside if SOL holds above the weekly support level at $128.68.
Canary Capital announced the launch of its spot Solana ETF, SOLC, on Tuesday, coinciding with Fidelity’s debut of the FSOL Solana ETF on the same day.
Fidelity becomes the fourth asset manager to roll out an SOL ETF and the first from the firm to feature staking. Moreover, Bitwise, which launched its product in late October, and Grayscale, whose fund also includes a staking component.
This succession of launches underscores accelerating institutional interest in Solana-based investment products, which projects a bullish outlook for Solana and its native token in the long term.
Solana price faced rejection at the daily level of $168.79 on November 11 and declined 22% over the next 6 days. On Tuesday, it recovered more than 7% after retesting the weekly support at $128.68. At the time of writing on Wednesday, it hovers around $139.71.
If the weekly support at $128.68 continues to hold, it could extend the recovery toward the next resistance at $160.
The Relative Strength Index (RSI) on the daily chart is 35, rebounding from the oversold territory, suggesting bearish momentum may be slowing and a potential short-term rebound could emerge.

On the other hand, if SOL closes below $128.68, it could extend the decline toward the next daily support at $118.10.
Wizzwoods has secured a fresh $10 million investment. The round included Animoca Brands, IVC, and several angel investors. The team says this funding will help them build faster and deliver a bigger experience for players.
Wizzwoods is an open-world farming strategy game. It lives inside the Telegram Mini-app and Twitter Extensions ecosystem. Players explore a large digital world. They farm resources, craft items, and complete strategic tasks. They can also trade assets, interact with others, and create unique content.
The game mixes blockchain ownership with simple gameplay. This makes it easy for new players to join while still giving advanced users room to build deeper strategies.
Wizzwoods focuses on a blend of creation, management, and competition. Players gather resources, build structures, and shape their land. The world is open and encourages exploration.
The game includes user generated content tools. Players can design items, create mini experiences, or contribute to the growing in-game ecosystem.
Multiplayer features allow players to team up or compete. Cross chain trading lets users move digital items across supported networks. This creates a dynamic market where rarity and skill can influence value.
The project says its goal is to build a community driven game world that grows over time. The new funding will speed up this process.
The investment will help the team expand the Wizzwoods universe. Key areas of focus include:
The team says they want to deliver an experience that feels alive. They also want to make onboarding simple for everyday players who are not familiar with blockchain.
This milestone also positions Wizzwoods as a rising name in web3 gaming. Animoca Brands continues to back projects that combine digital ownership with strong gameplay. Their involvement gives the project more credibility and industry access.
Even with the funding success, the Wizzwoods token has faced heavy pressure in the market.
WIZZ is currently priced at $0.000748. It has dropped 18.9 percent over the past twenty four hours. The token is down 97.4 percent from its all time high of $0.0286 on April 1, 2025.
The circulating supply sits at 423 million tokens. The maximum supply is 1.8 billion tokens. The token’s market cap is $316 thousand. Its trading volume over the past twenty four hours is just under $10 thousand. Gate remains the main exchange where it is traded.
The project holds 0 percent share of the broader crypto market. The team has not commented on price action. For now, they remain focused on building and expanding the game world.
Even with token volatility, investor confidence remains strong. Web3 gaming continues to attract long term capital. Investors see potential in games that bridge simple gameplay with blockchain features that give users ownership.
The Telegram Mini-app ecosystem is also growing fast. Games like Hamster Kombat and Notcoin have shown the power of viral mini games. Wizzwoods wants to tap into this momentum with a deeper strategy experience.
Investors believe the game is positioned to reach millions of users. The blend of farming, trading, and content creation makes it accessible to a wide audience.
More News: Jeff Bezos Bets $6.2 Billion on Physical AI
The team says development will move faster from here. Players can expect more features, better graphics, and new systems that enrich the world.
Wizzwoods plans to focus heavily on user generated content. They want players to build structures, design items, and even create storylines. This helps the world grow without limits.
The team also plans to expand trading tools. They want to make cross chain trading smooth and secure. This will help users build real value inside the game.
Wizzwoods is now one of the latest projects pushing web3 gaming into a new phase. The team has funding, a growing community, and a clear vision.
The game blends fun gameplay with blockchain ownership in a way that feels natural. If the team delivers on its roadmap, Wizzwoods could become one of the next big names in the Telegram gaming universe.
To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insight.
Platinum price surrendered to stochastic negativity, providing continuous strong pressure on the extra support at $1520.00 to activate the bearish corrective track.
We will keep waiting for confirming the break to open the way for targeting several negative stations that are located near $1480.00 reaching the moving average 55 at $1440.00, while the failure to confirm the break will force it to provide unstable mixed trading, and there is a new chances for testing $1605.00 barrier.
The expected trading range for today is between $1482.00 and $1565.00
Trend forecast: Bearish